mci 176 has been researched along with Coronary Disease in 1 studies
*Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, Y; Abiko, Y; Ichihara, K | 1 |
1 other study(ies) available for mci 176 and Coronary Disease
| Article | Year |
|---|---|
Effects of MCI-176, a new quinazolinone calcium antagonist, on myocardial energy and carbohydrate metabolism in ischemic dog hearts.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Calcium Channel Blockers; Carbohydrate Metabolism; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Male; Myocardium; Phosphocreatine; Phosphofructokinase-1; Quinazolines; Quinazolinones | 1991 |